|
|
Previous Article | Table of Contents | Next Article 
Rapid and sustained hematopoietic recovery in lethally irradiated mice
transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cells
N Uchida, HL Aguila, WH Fleming, L Jerabek and IL Weissman
Department of Pathology, Stanford University School of Medicine, CA 94305.
Hematopoietic stem cells (HSCs) are believed to play a critical role in the
sustained repopulation of all blood cells after bone marrow transplantation
(BMT). However, understanding the role of HSCs versus other hematopoietic
cells in the quantitative reconstitution of various blood cell types has
awaited methods to isolate HSCs. A candidate population of mouse HSCs,
Thy-1.1lo Lin-Sca-1+ cells, was isolated several years ago and, recently,
this population has been shown to be the only population of BM cells that
contains HSCs in C57BL/Ka-Thy-1.1 mice. As few as 100 of these cells can
radioprotect 95% to 100% of irradiated mice, resulting long-term
multilineage reconstitution. In this study, we examined the reconstitution
potential of irradiated mice transplanted with purified Thy-1.1lo
Lin-Sca-1+ BM cells. Donor-derived peripheral blood (PB) white blood cells
were detected as early as day 9 or 10 when 100 to 1,000 Thy-1.1lo
Lin-Sca-1+ cells were used, with minor dose-dependent differences. The
reappearance of platelets by day 14 and thereafter was also seen at all HSC
doses (100 to 1,000 cells), with a slight dose-dependence. All studied HSC
doses also allowed RBC levels to recover, although at the 100 cell dose a
delay in hematocrit recovery was observed at day 14. When irradiated mice
were transplanted with 500 Thy-1.1lo Lin-Sca-1+ cells compared with 1 x
10(6) BM cells (the equivalent amount of cells that contain 500 Thy-1.1lo
Lin-Sca-1+ cells as well as progenitor and mature cells), very little
difference in the kinetics of recovery of PB, white blood cells, platelets,
and hematocrit was observed. Surprisingly, even when 200 Thy1.1lo Lin-Sca-
1+ cells were mixed with 4 x 10(5) Sca-1- BM cells in a competitive
repopulation assay, most of the early (days 11 and 14) PB myeloid cells
were derived from the HSC genotype, indicating the superiority of the
Thy-1.1lo Lin-Sca-1+ cells over Sca-1- cells even in the early phases of
myeloid reconstitution. Within the Thy-1.1lo Lin-Sca-1+ population, the
Rhodamine 123 (Rh123)hi subset dominates in PB myeloid reconstitution at 10
to 14 days, only to be overtaken by the Rh123lo subset at 3 weeks and
thereafter. These findings indicate that HSCs can account for the early
phase of hematopoietic recovery, as well as sustained hematopoiesis, and
raise questions about the role of non-HSC BM populations in the setting of
BMT.
Volume 83,
Issue 12,
pp. 3758-3779,
06/15/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Si, A. C. Pulliam, Y. Linka, S. Ciccone, C. Leurs, J. Yuan, O. Eckermann, S. Fruehauf, S. Mooney, H. Hanenberg, et al.
Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells
Blood,
December 1, 2008;
112(12):
4458 - 4465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. L. Weissman and J. A. Shizuru
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
Blood,
November 1, 2008;
112(9):
3543 - 3553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Luth, S. J. Jun, M. K. Wessen, K. Liadaki, E. Gussoni, and L. M. Kunkel
Bone marrow side population cells are enriched for progenitors capable of myogenic differentiation
J. Cell Sci.,
May 1, 2008;
121(9):
1426 - 1434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Qian, E. Georges-Labouesse, A. Nystrom, A. Domogatskaya, K. Tryggvason, S. E. W. Jacobsen, and M. Ekblom
Distinct roles of integrins {alpha}6 and {alpha}4 in homing of fetal liver hematopoietic stem and progenitor cells
Blood,
October 1, 2007;
110(7):
2399 - 2407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Stripp and S. D. Reynolds
Bioengineered Lung Epithelium: Implications for Basic and Applied Studies in Lung Tissue Regeneration
Am. J. Respir. Cell Mol. Biol.,
February 1, 2005;
32(2):
85 - 86.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Visnjic, Z. Kalajzic, D. W. Rowe, V. Katavic, J. Lorenzo, and H. L. Aguila
Hematopoiesis is severely altered in mice with an induced osteoblast deficiency
Blood,
May 1, 2004;
103(9):
3258 - 3264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Chao, S. G. Emerson, and K. I. Weinberg
Stem Cell Transplantation (Cord Blood Transplants)
Hematology,
January 1, 2004;
2004(1):
354 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Bailey, S. Jiang, M. Afentoulis, C. I. Baumann, D. A. Schroeder, S. B. Olson, M. H. Wong, and W. H. Fleming
Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells
Blood,
January 1, 2004;
103(1):
13 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Komatsu, M. Mammolenti, M. Jones, R. Jurecic, T. J. Sayers, and R. B. Levy
Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing
Blood,
May 15, 2003;
101(10):
3991 - 3999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lin, K. Cordes, L. Li, L. Hood, W. G. Couser, S. J. Shankland, and P. Igarashi
Hematopoietic Stem Cells Contribute to the Regeneration of Renal Tubules after Renal Ischemia-Reperfusion Injury in Mice
J. Am. Soc. Nephrol.,
May 1, 2003;
14(5):
1188 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Hackney, P. Charbord, B. P. Brunk, C. J. Stoeckert, I. R. Lemischka, and K. A. Moore
A molecular profile of a hematopoietic stem cell niche
PNAS,
October 1, 2002;
99(20):
13061 - 13066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Orwig, M. R. Avarbock, and R. L. Brinster
Retrovirus-Mediated Modification of Male Germline Stem Cells in Rats
Biol Reprod,
September 1, 2002;
67(3):
874 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Friedman, V. I. Rebel, R. Derby, K. Bell, T.-T. Huang, F. A. Kuypers, C. J. Epstein, and S. J. Burakoff
Absence of Mitochondrial Superoxide Dismutase Results in a Murine Hemolytic Anemia Responsive to Therapy with a Catalytic Antioxidant
J. Exp. Med.,
April 16, 2001;
193(8):
925 - 934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Abkowitz, D. Golinelli, D. E. Harrison, and P. Guttorp
In vivo kinetics of murine hemopoietic stem cells
Blood,
November 15, 2000;
96(10):
3399 - 3405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Cheng, N. Rodrigues, H. Shen, Y. Yang, D. Dombkowski, M. Sykes, and D. T. Scadden
Hematopoietic Stem Cell Quiescence Maintained by p21cip1/waf1
Science,
March 10, 2000;
287(5459):
1804 - 1808.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. B. Deisseroth
Clinical Trials Involving Multidrug Resistance Transcription Units in Retroviral Vectors
Clin. Cancer Res.,
July 1, 1999;
5(7):
1607 - 1609.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Brandt, A. M. Bartholomew, J. D. Fortman, M. C. Nelson, E. Bruno, L. M. Chen, J. V. Turian, T. A. Davis, J. P. Chute, and R. Hoffman
Ex Vivo Expansion of Autologous Bone Marrow CD34+ Cells With Porcine Microvascular Endothelial Cells Results in a Graft Capable of Rescuing Lethally Irradiated Baboons
Blood,
July 1, 1999;
94(1):
106 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Cheshier, S. J. Morrison, X. Liao, and I. L. Weissman
In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
PNAS,
March 16, 1999;
96(6):
3120 - 3125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. AKASHI, M. KONDO, S. CHESHIER, J. SHIZURU, K. GANDY, J. DOMEN, R. MEBIUS, D. TRAVER, and I.L. WEISSMAN
Lymphoid Development from Stem Cells and the Common Lymphocyte Progenitors
Cold Spring Harb Symp Quant Biol,
January 1, 1999;
64(0):
1 - 12.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tricot, Y. Gazitt, T. Leemhuis, S. Jagannath, K.R. Desikan, D. Siegel, A. Fassas, S. Tindle, J. Nelson, C. Juttner, et al.
Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma
Blood,
June 15, 1998;
91(12):
4489 - 4495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bomberger, M. Singh-Jairam, G. Rodey, A. Guerriero, A. M. Yeager, W. H. Fleming, H. K. Holland, and E. K. Waller
Lymphoid Reconstitution After Autologous PBSC Transplantation With FACS-Sorted CD34+ Hematopoietic Progenitors
Blood,
April 1, 1998;
91(7):
2588 - 2600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. J. M. Zijlmans, J. W. M. Visser, L. Laterveer, K. Kleiverda, D. P. M. Heemskerk, P. M. Kluin, R. Willemze, and W. E. Fibbe
The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells
PNAS,
January 20, 1998;
95(2):
725 - 729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Rappold, B. L. Ziegler, I. Kohler, S. Marchetto, O. Rosnet, D. Birnbaum, P. J. Simmons, A. C.W. Zannettino, B. Hill, S. Neu, et al.
Functional and Phenotypic Characterization of Cord Blood and Bone Marrow Subsets Expressing FLT3 (CD135) Receptor Tyrosine Kinase
Blood,
July 1, 1997;
90(1):
111 - 125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Blair, D.E. Hogge, L.E. Ailles, P.M. Lansdorp, and H.J. Sutherland
Lack of Expression of Thy-1 (CD90) on Acute Myeloid Leukemia Cells With Long-Term Proliferative Ability In Vitro and In Vivo
Blood,
May 1, 1997;
89(9):
3104 - 3112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Morrison, A. Wandycz, H. Hemmati, D. Wright, and I. Weissman
Identification of a lineage of multipotent hematopoietic progenitors
Development,
January 5, 1997;
124(10):
1929 - 1939.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Hanania, R. E. Giles, J. Kavanagh, D. Ellerson, Z. Zu, T. Wang, Y. Su, A. Kudelka, Z. Rahman, F. Holmes, et al.
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy
PNAS,
December 24, 1996;
93(26):
15346 - 15351.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|